Skip to content

   Pharma Publications

Neuropsychopharmacology
  • Identifying brain-penetrant small-molecule modulators of human microglia using a cellular model of synaptic pruning
    Published on 2025-05-09
    7 months ago
  • Posttraining noradrenergic stimulation maintains hippocampal engram reactivation and episodic-like specificity of remote memory
    Published on 2025-05-08
    7 months ago
  • Antipsychotics cause reversible structural brain changes within one week
    Published on 2025-05-07
    7 months ago
  • Multi-ancestry genome-wide association meta-analysis of buprenorphine treatment response
    Published on 2025-05-06
    7 months ago
  • Circular RNAs as a novel player in synaptic transmission and neuropsychiatric disorders
    Published on 2025-05-06
    7 months ago
  • Sequential decreases in basolateral amygdala response to threat predict failure to recover from PTSD
    Published on 2025-05-03
    7 months ago
  • A Drd1-cre mouse line with nucleus accumbens gene dysregulation exhibits blunted fentanyl seeking
    Published on 2025-05-02
    7 months ago
« Previous 1 … 22 23 24 25 26 … 143 Next »
Journal of Psychopharmacology
  • Exploring the effects of erythropoietin treatment on cortical thickness and hippocampal volume in patients with mood disorders undergoing electroconvulsive therapy: A randomized, placebo-controlled trial
    Published on 2024-11-29
    1 year ago
  • Ketamine for treatment-resistant obsessive-compulsive disorder: Double-blind active-controlled crossover study
    Published on 2024-11-29
    1 year ago
  • Repurposing of erythropoietin as a neuroprotective agent against methotrexate-induced neurotoxicity in rats
    Published on 2024-11-13
    1 year ago
  • Promising strategies for the prevention of alcohol-related brain damage through optimised management of acute alcohol withdrawal: A focussed literature review
    Published on 2024-11-12
    1 year ago
  • Responses to clinical treatment of bipolar versus unipolar depressive episodes in women versus men
    Published on 2024-11-08
    1 year ago
  • Benzodiazepines for PTSD: Poor data quality and misleading advice
    Published on 2024-10-31
    1 year ago
  • Psilocybin for major depressive disorder: An updated systematic review and meta-analysis of randomized clinical trials
    Published on 2024-10-31
    1 year ago
« Previous 1 … 22 23 24 25 26 … 134 Next »
European Neuropsychopharmacology
  • “The role of gut microbiota in adult attention deficit hyperactivity disorder: Insights and implications”
    Published on 2024-11-07
    1 year ago
  • A meta-analysis of data-driven cognitive subgroups in bipolar disorder
    Published on 2024-11-06
    1 year ago
  • Placental epigenetic signatures of maternal distress in glucocorticoid-related genes and newborn outcomes: A study of Spanish primiparous women
    Published on 2024-11-06
    1 year ago
  • Efficacy and safety profile of oral creatine monohydrate in add-on to cognitive-behavioural therapy in depression: An 8-week pilot, double-blind, randomised, placebo-controlled feasibility and exploratory trial in an under-resourced area
    Published on 2024-11-02
    1 year ago
  • Does 18 Hz deep TMS benefit a different subgroup of depressed patients relative to 10 Hz rTMS? The role of the individual alpha frequency
    Published on 2024-10-12
    1 year ago
  • Towards a consensus roadmap for a new diagnostic framework for mental disorders
    Published on 2024-09-28
    1 year ago
  • Collaborative outcomes study on health and functioning during infection times (COH-FIT): Insights on modifiable and non-modifiable risk and protective factors for wellbeing and mental health during the COVID-19 pandemic from multivariable and network analyses
    Published on 2024-09-28
    1 year ago
« Previous 1 … 22 23 24 25 26 … 153 Next »

   Pharma Pub